These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 32267732)

  • 21. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
    Schluenz LA; Ramos-Otero GP; Nawarskas JJ
    Cardiol Rev; 2020; 28(5):266-271. PubMed ID: 32769401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
    Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
    Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging cardiological issues during the COVID-19 pandemic.
    Everaert BR; Muylle J; Bartholomeus Twickler T
    Eur J Clin Invest; 2020 Jul; 50(7):e13270. PubMed ID: 32415992
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
    Rosenberg ES; Dufort EM; Udo T; Wilberschied LA; Kumar J; Tesoriero J; Weinberg P; Kirkwood J; Muse A; DeHovitz J; Blog DS; Hutton B; Holtgrave DR; Zucker HA
    JAMA; 2020 Jun; 323(24):2493-2502. PubMed ID: 32392282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.
    Saleh M; Gabriels J; Chang D; Fishbein J; Qiu M; Mountantonakis SE; Epstein LM;
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008937. PubMed ID: 33003964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
    Ehrlich H; Elkbuli A
    Am J Emerg Med; 2021 Oct; 48():363-364. PubMed ID: 33551245
    [No Abstract]   [Full Text] [Related]  

  • 27. Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.
    Szekely Y; Lichter Y; Shrkihe BA; Bruck H; Oster HS; Viskin S
    Heart Rhythm; 2020 Sep; 17(9):1452-1455. PubMed ID: 32380291
    [No Abstract]   [Full Text] [Related]  

  • 28. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auditory Cinchonism in COVID Era.
    Saniasiaya J; Kulasegarah J
    Ear Nose Throat J; 2020 Nov; 99(9):597-598. PubMed ID: 32744901
    [No Abstract]   [Full Text] [Related]  

  • 30. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.
    Chang D; Saleh M; Gabriels J; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Epstein LM
    J Am Coll Cardiol; 2020 Jun; 75(23):2992-2993. PubMed ID: 32330546
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.
    Samuel S; Friedman RA; Sharma C; Ganigara M; Mitchell E; Schleien C; Blaufox AD
    Heart Rhythm; 2020 Nov; 17(11):1960-1966. PubMed ID: 32621881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.
    Medeiros-Domingo A; Carrasco OF; Berni-Betancourt A
    Arch Cardiol Mex; 2020; 90(Supl):36-40. PubMed ID: 32523150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
    Machiels JD; Bleeker-Rovers CP; Ter Heine R; Rahamat-Langendoen J; de Mast Q; Ten Oever J; Bousema T; van Crevel R; Wertheim HF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106056. PubMed ID: 32674929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
    Anupama BK; Adhikari S; Chaudhuri D
    J Investig Med High Impact Case Rep; 2020; 8():2324709620948407. PubMed ID: 32762368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine in Covid-19: Does the end justify the means?
    Yakoub-Agha I
    Curr Res Transl Med; 2020 Aug; 68(3):81-82. PubMed ID: 32340837
    [No Abstract]   [Full Text] [Related]  

  • 38. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
    Gérard A; Romani S; Fresse A; Viard D; Parassol N; Granvuillemin A; Chouchana L; Rocher F; Drici MD;
    Therapie; 2020; 75(4):371-379. PubMed ID: 32418730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.
    Jankelson L; Karam G; Becker ML; Chinitz LA; Tsai MC
    Heart Rhythm; 2020 Sep; 17(9):1472-1479. PubMed ID: 32438018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
    Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.